New tool aims to help people decide on Multi-Cancer blood tests
NCT ID NCT06870916
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to develop an educational aid to help people make informed decisions about multi-cancer early detection (MCED) blood tests. Researchers will hold focus groups with 150 participants to discuss knowledge, preferences, and concerns about these tests. The goal is to create a tool that clearly explains the risks and benefits of MCED screening.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could create a tool that helps people better understand and decide about multi-cancer early detection blood tests.
- What could go wrong
- This is a small, suspended focus group study to develop an educational aid, not a test of the screening itself. It may not lead to widespread use or improved health outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTI-CANCER EARLY DETECTION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States